FIELD: medicine.
SUBSTANCE: described is device for transcutaneous introduction of nicotine, which ensures basic as well as additional introduction of nicotine activated by user. Invention also describes device for combined basic and additional transcutaneous delivery of nicotine activated by user ensuring different rates of nicotine delivery to individual.
EFFECT: increase in means efficiency.
13 cl, 6 dwg, 3 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BUFFERED LIQUID NICOTINE COMPOSITION FOR PULMONARY ADMINISTRATION | 2003 |
|
RU2283111C2 |
| TRANSCUTANEOUS PATCH WITH MICRONEEDLES CONTAINING DONEPEZIL | 2018 |
|
RU2735835C1 |
| LIQUID COMPOSITION FOR NICOTINE DELIVERY | 2008 |
|
RU2457822C2 |
| TRANSDERMAL PHARMACEUTICAL PREPARATION AND ADMINISTERING TIROFIBAN | 2010 |
|
RU2539398C2 |
| NICOTINE COMPOSITION FOR PERORAL APPLICATION, WHICH CONTAINS AMINO-ACID BUFFER | 2008 |
|
RU2465904C2 |
| COMPOSITION PROMOTING SMOKING CEASING, METHOD OF TOBACCO SMOKING DEPENDENCE DECREASE (VARIANTS), METHOD OF TOBACCO SMOKING SUBSTITUTION (VARIANTS) | 1993 |
|
RU2118897C1 |
| REMEDY FOR THOSE QUITTING SMOKING | 2021 |
|
RU2782018C1 |
| SYSTEM FOR TRANSCUTANEOUS ADMINISTRATION OF NICOTINE(85)18.06.2001 | 1999 |
|
RU2246937C2 |
| TRANSDERMAL DELIVERY OF HIGH-BINDED BIOACTIVE AGENTS | 2012 |
|
RU2630610C2 |
| LIQUID PHARMACEUTICAL COMPOSITION COMPRISING NICOTINE FOR ADMINISTRATION INTO MOUTH CAVITY | 2002 |
|
RU2279871C2 |
